Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 1,415,096 | 1,417,942 | 1,385,554 | 1,420,951 | 1,292,014 |
| Cost of Goods | 133,749 | 133,827 | 139,358 | 139,112 | 133,197 |
| Gross Profit | 1,281,347 | 1,284,115 | 1,246,196 | 1,281,839 | 1,158,817 |
| Operating Expenses | 771,571 | 839,436 | 711,304 | 776,228 | 789,644 |
| Operating Income | 510,525 | 445,506 | 535,250 | 505,723 | 369,370 |
| Other Income | -18,268 | -17,039 | -5,806 | 2,439 | 15,144 |
| Pre-tax Income | 492,257 | 428,467 | 529,444 | 508,162 | 384,514 |
| Income Tax | 65,508 | 136,341 | 131,044 | 121,021 | 82,148 |
| Net Income Continuous | 426,749 | 292,126 | 398,400 | 387,141 | 302,366 |
| Minority Interests | N/A | N/A | N/A | 295 | -295 |
| Net Income | $426,749 | $292,126 | $398,400 | $386,846 | $302,661 |
| EPS Basic Total Ops | 1.80 | 1.24 | 1.68 | 1.62 | 1.26 |
| EPS Basic Continuous Ops | 1.80 | 1.23 | 1.68 | 1.62 | 1.26 |
| EPS Diluted Total Ops | 1.79 | 1.23 | 1.67 | 1.61 | 1.25 |
| EPS Diluted Continuous Ops | 1.79 | 1.22 | 1.67 | 1.61 | 1.25 |
| EBITDA(a) | $607,978 | $542,382 | $629,453 | $596,347 | $453,315 |